Inhibition of AKT2 Enhances Sensitivity to Gemcitabine via Regulating PUMA and NF-κB Signaling Pathway in Human Pancreatic Ductal Adenocarcinoma

Invasion, metastasis and resistance to conventional chemotherapeutic agents are obstacles to successful treatment of pancreatic cancer, and a better understanding of the molecular basis of this malignancy may lead to improved therapeutics. In the present study, we investigated whether AKT2 silencing...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Dong, Niu, Min, Jiao, Xuelong, Zhang, Kejun, Liang, Jun, Zhang, Dianliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269746/
https://www.ncbi.nlm.nih.gov/pubmed/22312312
http://dx.doi.org/10.3390/ijms13011186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269746/
https://www.ncbi.nlm.nih.gov/pubmed/22312312
http://dx.doi.org/10.3390/ijms13011186

Ejemplares similares